{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:23:24Z","timestamp":1777073004686,"version":"3.51.4"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"Supplement_2","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,7]]},"DOI":"10.1093\/cid\/ciy1118","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T03:33:10Z","timestamp":1547004790000},"page":"S171-S176","source":"Crossref","is-referenced-by-count":11,"title":["Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?"],"prefix":"10.1093","volume":"68","author":[{"given":"Leslie P","family":"Jamka","sequence":"first","affiliation":[{"name":"Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth W","family":"Simiyu","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adwoa D","family":"Bentsi-Enchill","sequence":"additional","affiliation":[{"name":"Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziza J","family":"Mwisongo","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Matzger","sequence":"additional","affiliation":[{"name":"Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony A","family":"Marfin","sequence":"additional","affiliation":[{"name":"Center for Vaccine Innovation and Access, PATH, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J","family":"Pollard","sequence":"additional","affiliation":[{"name":"Oxford Vaccine Group, Department of Paediatrics, University of Oxford, and the NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M","family":"Neuzil","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health at the University of Maryland School of Medicine, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,3,7]]},"reference":[{"key":"key\n\t\t\t\t2019030806460067100_CIT0001","volume-title":"Typhoid: a preventable global health threat","year":"2017"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0002","first-page":"153","article-title":"Typhoid vaccines: WHO position paper, March 2018","volume":"13","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0003","year":"2017"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0004","first-page":"1211","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Marchello"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0005","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1111","article-title":"Antibiotic resistance and typhoid","author":"Dyson","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0006","first-page":"268","article-title":"PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries","volume":"22","author":"Levine","year":"2004","journal-title":"J Health Popul Nutr"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0007","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0264-410X(00)00239-5","article-title":"Infant and adolescent hepatitis B immunization up to 1999: a global overview","volume":"19","author":"Vryheid","year":"2000","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0008","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0264-410X(99)00269-8","article-title":"Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four \u2018newly adopting\u2019 countries","volume":"18","author":"Wenger","year":"1999","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0009","article-title":"In: The 11th International Symp\u200bo\u200bsium\u200b\u200b on Pneumococci and Pneumococc\u200bal Diseases (ISPPD-11)","volume-title":"Pneumococcal conjugate vaccine introduction and uptake timelines for Gavi-supported countries","author":"Luthra","year":"2018"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1377\/hlthaff.2015.1079","article-title":"Gavi\u2019s transition policy: moving from development assistance to domestic financing of immunization programs","volume":"35","author":"Kallenberg","year":"2016","journal-title":"Health Aff (Millwood)"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0011","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4161\/hv.6.12.13076","article-title":"A policy framework for accelerating adoption of new vaccines","volume":"6","author":"Levine","year":"2010","journal-title":"Hum Vaccin"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0012","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.vaccine.2010.07.028","article-title":"Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience","volume":"28","author":"Hajjeh","year":"2010","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0013","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.socscimed.2007.05.054","article-title":"What influences government adoption of vaccines in developing countries? A policy process analysis","volume":"65","author":"Munira","year":"2007","journal-title":"Social Sci Med (1982)"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0014","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/vim.2017.0120","article-title":"Lessons from the meningitis vaccine project","volume":"31","author":"LaForce","year":"2018","journal-title":"Viral Immunol"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0015","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/cid\/civ551","article-title":"Introduction and rollout of a new group A meningococcal conjugate vaccine (PsA-TT) in African meningitis belt countries, 2010\u20132014","volume":"61","author":"Djingarey","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0016","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.1016\/j.vaccine.2012.09.008","article-title":"Conducting vaccine clinical trials in sub-Saharan Africa: operational challenges and lessons learned from the meningitis vaccine project","volume":"30","author":"Marchetti","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0017","unstructured":"World Health Organization. Immunization coverage. Available at: http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage. Accessed 4 August 2018."},{"key":"key\n\t\t\t\t2019030806460067100_CIT0018","first-page":"11","article-title":"Japanese encephalitis virus: ecology and epidemiology","volume":"267","author":"Endy","year":"2002","journal-title":"Curr Top Microbiol Immunol"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0019","doi-asserted-by":"crossref","first-page":"61","DOI":"10.14202\/vetworld.2015.61-65","article-title":"Japanese encephalitis: challenges and intervention opportunities in Nepal","volume":"8","author":"Ghimire","year":"2015","journal-title":"Vet World"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/505121","article-title":"Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India","volume":"43","author":"Kumar","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0021","volume-title":"Japanese encephalitis vaccine introduction","year":"2009"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0022"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0023","doi-asserted-by":"crossref","first-page":"e1000249","DOI":"10.1371\/journal.pmed.1000249","article-title":"Accelerating policy decisions to adopt haemophilus influenzae type B vaccine: a global, multivariable analysis","volume":"7","author":"Shearer","year":"2010","journal-title":"PLoS Med"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0024","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1080\/13696998.2017.1359181","article-title":"Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review","volume":"20","author":"Chongmelaxme","year":"2017","journal-title":"J Med Econ"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0025"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0026","first-page":"285","article-title":"Rotavirus vaccines","volume":"82","year":"2007","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0027","volume-title":"Meeting of the immunization Strategic Advisory Group of Experts, November 2005\u2014recommendations and conclusions","year":"2006"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0028","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1086\/605042","article-title":"Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a World Health Organization-sponsored consultation","volume":"200","author":"Steele","year":"2009","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0029","first-page":"108","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants","volume":"28","author":"Madhi","year":"2016","journal-title":"Malawi Med J"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0030","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0031","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0032","volume-title":"Global introduction status"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0033","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1103","article-title":"TyVAC Malawi: a phase 3 randomized, double-blind, controlled trial of the clinical efficacy of typhoid conjugate vaccine among children aged 9 months through 12 years in Blantyre, Malawi: study protocol for a randomized controlled trial","author":"Meiring","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0034","article-title":"Assessing the impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infections among Nepalese children: a protocol for a phase 3 randomized controlled trial","author":"Theiss-Nyland","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0035","article-title":"Assessing the impact of a Vi-polysaccharide conjugate vaccine in preventing typhoid infection among Bangladeshi children: a protocol for a phase 3b trial","author":"Theiss-Nyland","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0036","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1104","article-title":"A phase 2 randomized, double-blind, controlled safety and immunogenicity trial of typhoid conjugate vaccine in children under 2 years of age in Ouagadougou, Burkina Faso: a methods paper","author":"Laurens","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0037","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4269\/ajtmh.18-0032","article-title":"Introductory article on global burden and epidemiology of typhoid fever","volume":"99","author":"Radhakrishnan","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0038","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1093\/cid\/civ693","article-title":"The Typhoid Fever Surveillance in Africa Program (TSAP): clinical, diagnostic, and epidemiological methodologies","volume":"62","author":"von Kalckreuth","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0039","volume-title":"Vaccine-preventable diseases surveillance standards typhoid and other invasive salmonellosis","year":"2018"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0040","volume-title":"Typhoid vaccine"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0041","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.vaccine.2018.04.022","article-title":"Typhoid vaccines: WHO position paper, March 2018\u2014recommendations","volume":"37","year":"2019","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0042","article-title":"Millions of children set to be protected against typhoid fever","year":"2017"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0043","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0044","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0045","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0046","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1076","article-title":"Forecasting demand for the typhoid conjugate vaccine in low- and middle-income countries","author":"Debellut","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0047","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijid.2016.02.187","article-title":"The surveillance for enteric fever in Asia project (SEAP): estimating the community burden of enteric fever","volume":"45","author":"Garrett","year":"2016","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0048","doi-asserted-by":"crossref","first-page":"S188","DOI":"10.1093\/infdis\/jiy522","article-title":"Phase I of the surveillance for enteric fever in Asia Project (SEAP): an overview and lessons learned","volume":"218","author":"Barkume","year":"2018","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0049","volume-title":"Severe Typhoid Fever Surveillance in Africa (SETA) program: first data from the 6 African sites","author":"Park","year":"2017"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0050","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1108","article-title":"Predicting the impact of typhoid conjugate vaccines on antimicrobial resistance","author":"Kaufhold","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0051","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy1115","article-title":"Time to control typhoid","author":"Pollard","year":"2019","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0052","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"mBio"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0053","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/nm1225","article-title":"Introducing new vaccines into developing countries: obstacles, opportunities and complexities","volume":"11","author":"Clemens","year":"2005","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0054","volume-title":"Principles and considerations for adding a vaccine to a national immunization programme: from decision to implementation and monitoring","year":"2014"},{"key":"key\n\t\t\t\t2019030806460067100_CIT0055","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1016\/j.vaccine.2014.07.076","article-title":"Experiences with provider and parental attitudes and practices regarding the administration of multiple injections during infant vaccination visits: lessons for vaccine introduction","volume":"32","author":"Wallace","year":"2014","journal-title":"Vaccine"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/Supplement_2\/S171\/28023944\/ciy1118.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:50:26Z","timestamp":1552045826000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/Supplement_2\/S171\/5371228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,7]]},"references-count":55,"journal-issue":{"issue":"Supplement_2","published-online":{"date-parts":[[2019,3,7]]},"published-print":{"date-parts":[[2019,3,7]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy1118","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3,15]]},"published":{"date-parts":[[2019,3,7]]}}}